
Mailbag: Learning Healthcare, Multiplicities, and the Pace of Innovation
Episode 84
In this mailbag episode of "In the Interim…", Dr. Scott Berry answers two listener questions and weighs in on the pace of innovation in clinical trial science. Asked what infrastructure a learning healthcare system would require, Scott defines one through the REMAP structure (randomized, embedded, multifactorial, adaptive platform) that Derek Angus named for REMAP-CAP, and uses REMAP Periop at UPMC to argue that embedding randomization and data collection in routine care keeps the cost low while letting a health system learn from tens of thousands of patients a year. On multiplicities, Scott explains why he interprets subgroups, endpoints, and related trials within a Bayesian hierarchical model rather than by adjusting alpha, with the assumed variability across units (tau) setting how far each estimate shrinks toward the overall effect, and he critiques hierarchical testing as non-Bayesian. The episode closes on the contrast between fast-moving innovation, including the AI-accelerated redesign of FACTS, Berry's clinical trial simulation platform, and ARPA-H's SURPASS call for adaptive platform trials, and the conservatism of the EMA's draft reflection paper on platform trials and ICH E20. Key Highlights REMAP (randomized, embedded, multifactorial, adaptive platform) as a working definition of a learning healthcare system. Embedding randomization and data collection in routine care to remove a large share of trial costs.
Publisher
In the Interim...
Link
share.transistor.fm/s/0dd6538f
Published
November 9, 2026
Duration
47 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
Host
Berry
In the Interim...
@intheinterim
#learninghealthcare #multiplicities #innovation #mathematics #medicine
